{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:05:13Z","timestamp":1790661913797,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Chemotherapy is one of the primary treatment options for cancer; however, its gastrointestinal toxicity and disruption of gut microbial homeostasis can adversely affect patient health and treatment outcomes. This study investigated chemotherapy-induced alterations in the gut microbiome and evaluated the effects of probiotic supplementation on microbial diversity, gastrointestinal toxicity, and treatment response in cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The probiotic strain was isolated from a commercial formulation and identified as Lactobacillus casei using biochemical characterization and 16S rRNA gene sequencing. Its secreted metabolites were characterized using Fourier-transform infrared spectroscopy (FTIR), gas chromatography\u2013mass spectrometry (GC-MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) spectroscopy. A total of 150 patients receiving platinum-based chemotherapy were enrolled and divided into control and probiotic intervention groups. Fecal samples were collected before and after chemotherapy and subjected to 16S rRNA sequencing to assess microbial diversity and taxonomic composition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Chemotherapy induced significant gut microbial dysbiosis, characterized by reduced alpha diversity, decreased abundance of beneficial bacteria, including Lactobacillus, Bifidobacterium, and Faecalibacterium, and increased abundance of opportunistic pathogens such as Escherichia-Shigella and Klebsiella. In contrast, probiotic-treated patients maintained a relatively balanced gut microbiota and exhibited less pronounced dysbiosis after chemotherapy. Gastrointestinal complications were also reduced following probiotic supplementation. Overall gastrointestinal toxicity was observed in 85% of control patients compared with 65% of probiotic-treated patients, while diarrhea occurred in 60% and 35%, respectively. Grade 3\u20134 gastrointestinal toxicity was reported in 40% of control patients compared with 20% of probiotic-treated patients. Probiotic supplementation was additionally associated with lower incidence and severity of mucositis, nausea, and vomiting. Chemotherapy responders exhibited a more favorable microbial profile with greater abundance of beneficial commensal bacteria than non-responders. Receiver operating characteristic analysis identified microbial taxa as potential predictors of chemotherapy outcomes, with AUC values of 0.81 for Bacteroides ovatus, 0.78 for Faecalibacterium prausnitzii, and 0.86 for the combined response model. The combined microbial model achieved an AUC of 0.88 for predicting severe gastrointestinal toxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Overall, probiotic supplementation may help preserve intestinal microbial homeostasis, reduce chemotherapy-associated gastrointestinal toxicity, and support improved treatment outcomes in cancer patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1887323","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:46:51Z","timestamp":1790660811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbiome-based probiotic intervention to reduce chemotherapy-induced gastrointestinal toxicity"],"prefix":"10.3389","volume":"16","author":[{"given":"Haoyu","family":"Li","sequence":"first","affiliation":[{"name":"Academy of Art and Design, Hankou University","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Hou","sequence":"additional","affiliation":[{"name":"General Surgery Department, Huangshi Hospital of Traditional Chinese Medicine","place":["Huangshi, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Pan","sequence":"additional","affiliation":[{"name":"College of Physical Education, Hubei Normal University","place":["Huangshi, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.999001","article-title":"Human gut microbiota in health and disease: Unveiling the relationship","volume":"13","author":"Afzaal","year":"2022","journal-title":"Front. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060879","article-title":"Probiotics and cancer: Mechanistic insights and organ-specific impact","volume":"15","author":"Ahmad","year":"2025","journal-title":"Biomolecules"},{"key":"B3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","article-title":"Chemotherapy induced gastrointestinal toxicities","volume":"155","author":"Akbarali","year":"2022","journal-title":"Adv. Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/13685538.2018.1488955","article-title":"Determination of oxidative stress levels and some antioxidant enzyme activities in prostate cancer","volume":"22","author":"Amar","year":"2019","journal-title":"Aging Male"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis."},{"key":"B6","first-page":"1","article-title":"Faecalibacterium: A bacterial genus with promising human health applications","volume":"47","author":"Berm\u00fadez-Humar\u00e1n","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.79636","article-title":"Weekly versus three-weekly administration of paclitaxel as neoadjuvant chemotherapy in HER2 negative, stage III breast cancer: A comparison of treatment responses","volume":"17","author":"Biswas","year":"2025","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41698-025-01034-0","article-title":"The role of the gut microbiota in chemotherapy response, efficacy and toxicity: A systematic review","volume":"9","author":"B\u00f6hm","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"22302","DOI":"10.1038\/s41598-021-01636-1","article-title":"Enhancing diversity analysis by repeatedly rarefying next generation sequencing data describing microbial communities","volume":"11","author":"Cameron","year":"2021","journal-title":"Sci. Rep."},{"key":"B10","first-page":"1","article-title":"Biological indicators of oxidative stress [malondialdehyde, catalase, glutathione peroxidase, and superoxide dismutase] and their application in nutrition","volume-title":"Biomarkers in Nutrition","author":"Carmo de Carvalho e Martins","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092141","article-title":"Gut microbiota dysbiosis and dietary interventions in non-Hodgkin B-cell lymphomas: Implications for treatment response","volume":"13","author":"Caserta","year":"2025","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116022","article-title":"Effects of probiotics on gut microbiota: An overview","volume":"25","author":"Chandrasekaran","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2025.03.002","article-title":"The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer","volume":"112","author":"Daniel","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jfutfo.2025.12.010","article-title":"Probiotic or synbiotic interventions and chemotherapy-associated diarrhea in cancer patients: A meta-analysis of randomized trials","author":"Ding","year":"2026","journal-title":"J. Future Foods"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.823288","article-title":"Oral administration of probiotics reduces chemotherapy-induced diarrhea and oral mucositis: A systematic review and meta-analysis","volume":"9","author":"Feng","year":"2022","journal-title":"Front. Nutr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1556\/2066.2025.00081","article-title":"The effect of probiotic supplementation on zonulin levels in healthy individuals\u2013A systematic review and meta-analysis","volume":"8","author":"F\u00f6ldv\u00e1ri-Nagy","year":"2025","journal-title":"Developments Health Sci."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092211","article-title":"Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910255","article-title":"Gut microbiota disruption in hematologic cancer therapy: Molecular insights and implications for treatment efficacy","volume":"25","author":"Guevara-Ram\u00edrez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.7150\/jca.99421","article-title":"Important role of intestinal microbiota in chemotherapy-induced diarrhea and therapeutics","volume":"16","author":"Jiang","year":"2025","journal-title":"J. Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.70029","article-title":"The role of microbiome and probiotics in chemo\u2010radiotherapy\u2010induced diarrhea: A narrative review of the current evidence","volume":"7","author":"Khorashadizadeh","year":"2024","journal-title":"Cancer Rep."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1216674","article-title":"Probiotics: Mechanism of action, health benefits and their application in food industries","volume":"14","author":"Latif","year":"2023","journal-title":"Front. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0322059","article-title":"Inulin promotes appetite in mice by regulating the gut microbiota under conditions of rapid entry to the plateau","volume":"20","author":"Li","year":"2025","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i8.108870","article-title":"Associations between serum biomarkers and gut microbial imbalance in predicting chemotherapy response in colorectal cancer: A retrospective analysis","volume":"17","author":"Ling","year":"2025","journal-title":"World J. Gastrointestinal Oncol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694344","article-title":"Mechanism of the immunomodulatory effect of the combination of live Bifidobacterium, Lactobacillus, Enterococcus, and Bacillus on immunocompromised rats","volume":"12","author":"Lv","year":"2021","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpeds.2024.100139","article-title":"Bifidobacteria, lactobacilli. when, how and why to use them","volume":"8","author":"Matera","year":"2024","journal-title":"Global Pediatr."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193305","article-title":"Mechanistic insights on microbiota-mediated development and progression of esophageal cancer","volume":"16","author":"Moe","year":"2024","journal-title":"Cancers"},{"key":"B27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy\u2010driven dysbiosis in the intestinal microbiome","volume":"42","author":"Montassier","year":"2015","journal-title":"Alimentary Pharmacol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-025-09913-z","article-title":"Microbiota-induced T cell plasticity enables immune-mediated tumour control","volume":"651","author":"Najar","year":"2026","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100155","DOI":"10.1016\/j.medmic.2025.100155","article-title":"The gut microbiota and breast cancer: A comprehensive review of emerging links and therapeutic implications","volume":"26","author":"Nazeer","year":"2025","journal-title":"Med. Microecol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i5.99913","article-title":"Unlocking the secrets of the human gut microbiota: Comprehensive review on its role in different diseases","volume":"31","author":"Paul","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18084265","article-title":"Probiotic supplements on oncology patients\u2019 treatment-related side effects: A systematic review of randomized controlled trials","volume":"18","author":"Rodriguez-Arrastia","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s12672-025-03574-0","article-title":"Gut microbiota as a hidden modulator of chemotherapy: Implications for colorectal cancer treatment","volume":"16","author":"Sadeghloo","year":"2025","journal-title":"Discover Oncol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.110881","article-title":"Impact of the Common Terminology Criteria for Adverse Events (CTCAE) evolution on toxicity scoring in gynaecological radiotherapy","volume":"207","author":"Spampinato","year":"2025","journal-title":"Radiotherapy Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3181\/0810-rm-301","article-title":"Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis","volume":"234","author":"Stringer","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.20944\/preprints202510.1581.v1","article-title":"The gut microbiome as a biomarker and therapeutic target of immune checkpoint inhibitors: A review for oncologists","volume":"14","author":"Susiriwatananont","year":"2025","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e703","DOI":"10.1093\/oncolo\/oyad060","article-title":"Characterization of gut microbiome composition in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy","volume":"28","author":"Vernaci","year":"2023","journal-title":"Oncologist"},{"key":"B37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.vetimm.2016.01.003","article-title":"Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species","volume":"172","author":"Vlasova","year":"2016","journal-title":"Veterinary Immunol. Immunopathology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000043126","article-title":"Efficacy and safety of probiotics in preventing chemotherapy-related diarrhea in patients with colorectal cancer: A systematic review and meta-analysis based on 18 randomized trials","volume":"104","author":"Yang","year":"2025","journal-title":"Medicine"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.977","article-title":"Absolute quantitation of microbes using 16S rRNA gene metabarcoding: A rapid normalization of relative abundances by quantitative PCR targeting a 16S rRNA gene spike\u2010in standard","volume":"9","author":"Zemb","year":"2020","journal-title":"Microbiol. Open"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1690541","article-title":"Gut microbiome alterations and their clinical and biological implications in ovarian cancer: A systematic review","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Oncol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1143548","article-title":"Probiotics fortify intestinal barrier function: A systematic review and meta-analysis of randomized trials","volume":"14","author":"Zheng","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1887323\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:46:52Z","timestamp":1790660812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1887323\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":41,"alternative-id":["10.3389\/fcimb.2026.1887323"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1887323","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"article-number":"1887323"}}